Rocket Pharmaceuticals · 9 hours ago
Summer Intern - Quality Control
Cranbury, NJ
Internship
Onsite
InternRocket Pharmaceuticals is a fully integrated biotechnology company focused on advancing gene therapies. The internship offers university students hands-on experience in Quality Control, supporting projects that ensure product quality and safety in a laboratory environment.
BiotechnologyGeneticsHealth CarePharmaceutical
Responsibilities
Assist with organizing assay file system
Help develop and organize retain and reserve inspections
Participate in routine laboratory cleaning and maintenance
Assist facilitating proper storage of reagents, materials, and consumables in QC laboratories
Participate in troubleshooting and problem-solving for Quality Control issues
Collaborate with cross-functional teams, including Quality, Warehouse, Facilities, and Environmental Health & Safety (EHS) to execute projects successfully
Qualification
Required
Rising junior or senior undergrad BS majoring in Chemistry, Biology, Immunology or a related field
Ability to read and interpret standard operation procedures and specifications
Proficiency in Microsoft Office Suite (Excel, Word, PowerPoint)
Knowledge of Good Manufacturing Practices (GMP) and regulatory requirements
Great organizational and time management skills, with strong attention to detail
Strong communication and interpersonal skills
Ability to follow instructions and work independently
Company
Rocket Pharmaceuticals
Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.
Founded in 2015
201-500 employees
H1B Sponsorship
Rocket Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (1)
2023 (2)
2022 (1)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$891.36MKey Investors
RTW InvestmentsCalifornia Institute for Regenerative Medicine
2023-09-12Post Ipo Equity· $175M
2022-10-03Post Ipo Equity· $100.3M
2021-08-30Post Ipo Equity· $26.4M
Leadership Team
Gaurav Shah
CEO and President
Jonathan Schwartz
Chief Scientific and Gene Therapy Officer
Recent News
2026-01-16
2025-12-09
2025-11-24
Company data provided by crunchbase